John B Buse
University of North Carolina at Chapel Hill
H-index: 137
North America-United States
Top articles of John B Buse
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT … | American Heart Journal | Stephen J Nicholls Deepak L Bhatt John B Buse Stefano Del Prato Steven E Kahn | 2024/1/1 |
Mortality in Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE) | Diabetes Care | Mary Ann Banerji John B Buse Naji Younes Heidi Krause-Steinrauf Adline Ghazi | 2024/1/22 |
Efficacité de la metformine en prévention d’un covid long chez les patients non hospitalisés avec excès pondéral? A confirmer! | Minerva | CT Bramante JB Buse DM Liebovitz | 2024 |
Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019 | Clinical Infectious Diseases | Carolyn T Bramante Kenneth B Beckman Tanvi Mehta Amy B Karger David J Odde | 2024/5/1 |
Reflecting on a Year at the Helm of Diabetes Care | Steven E Kahn Cheryl AM Anderson John B Buse Elizabeth Selvin Sonia Y Angell | 2024/1/1 | |
Association of Premorbid GLP-1RA and SGLT-2i Prescription Alone and in Combination with COVID-19 Severity | Diabetes Therapy | Klara R Klein Trine J Abrahamsen Anna R Kahkoska G Caleb Alexander Christopher G Chute | 2024/5 |
COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry | Journal of thrombosis and haemostasis | Anjali Sharathkumar Linder Wendt Chris Ortman Ragha Srinivasan Christopher G Chute | 2024/1/1 |
Differential Effects of Type 2 Diabetes Treatment Regimens on Diabetes Distress and Depressive Symptoms in the Glycemia Reduction Approaches in Diabetes: A Comparative … | Diabetes Care | Jeffrey S Gonzalez Ionut Bebu Heidi Krause-Steinrauf Claire J Hoogendoorn Gladys Crespo-Ramos | 2024/2/28 |
CATALYST: A Phase 4 Study of Hypercortisolism in Patients with Difficult-to-Control Type 2 Diabetes Despite Receiving Standard-of-Care Therapies Assessing Prevalence and … | American Heart Journal | Juan P Frias Richard J Auchus Irina Bancos Lawrence Blonde Robert S Busch | 2024/1/1 |
Regional variation in cause of death in patients with type 2 diabetes: insights from EXSCEL: Cause of Death in Type 2 Diabetes | American Heart Journal | Vishal N Rao Abhinav Sharma Amanda Stebbins John B Buse Brian G Katona | 2024/2/22 |
Impact of Continuous Glucose Monitoring Initiation on Emergency Health Services Utilization | Diabetes Care | Joshua M Weinstein Ben Urick Shweta Pathak Kathryn A Fuller Joseph Albright | 2023/8/1 |
Case study of semaglutide and cardiovascular outcomes: An application of the Causal Roadmap to a hybrid design for augmenting an RCT control arm with real-world data | Journal of Clinical and Translational Science | Lauren E Dang Edwin Fong Jens Magelund Tarp Kim Katrine Bjerring Clemmensen Henrik Ravn | 2023/1 |
A framework for assessing clinical trial site readiness | Journal of Clinical and Translational Science | John B Buse Christopher P Austin S Claiborne Johnston Freda Lewis-Hall Andrew N March | 2023/1 |
Use of comprehensive recruitment strategies in the Glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE) multi-center clinical trial | Clinical Trials | Andrea L Cherrington Heidi Krause-Steinrauf Vanita Aroda John B Buse Basma Fattaleh | 2023/10 |
Liraglutide as a potential drug repurposing candidate for Alzheimer’s disease and related dementia: Real World Evidence | Alzheimer's & Dementia | Tiansheng Wang John B Buse Virginia Pate Gwenn A Garden Til Stürmer | 2023/12 |
Pre-existing autoimmunity is associated with increased severity of COVID-19: A retrospective cohort study using data from the National COVID Cohort Collaborative (N3C) | medRxiv | Arjun S Yadaw Behdad Afzali Nathan Hotaling Hythem Sidky Emily R Pfaff | 2023/2/4 |
Increased derived time in range is associated with reduced risk of major adverse cardiovascular events, severe hypoglycemia, and microvascular events in type 2 diabetes: a post … | Diabetes Technology & Therapeutics | Richard M Bergenstal Elise Hachmann-Nielsen Kajsa Kvist Anne L Peters Jens Magelund Tarp | 2023/6/1 |
68 Metformin prevents the diagnosis of Long Covid in phase 3 trial of early treatment. | Journal of Clinical and Translational Science | Carolyn Bramante Esteban Wirtz John Buse David Boulware Jacinda Nicklas | 2023/4 |
1802-PUB: Liraglutide as a Potential Drug Repurposing Candidate for Alzheimer’s Disease and Related Dementia—Real-World Evidence | Diabetes | TIANSHENG WANG JOHN B BUSE VIRGINIA PATE TIL STÜRMER | 2023/6/20 |
Does Daily Self-Monitoring of Blood Sugar Levels Improve Blood Sugar Control and Quality of Life for Patients with Type 2 Diabetes Who Do Not Use Insulin?–The Monitor Trial | Laura A Young John B Buse Mark A Weaver Maihan B Vu C Madeline Mitchell | 2023/12/20 |
